Objective: To discuss the clinical features of pregnant women with hypertrophic cardiomyopathy (HCM).
Methods: There were 28 patients with HCM who delivered in Renji hospital of Shanghai Jiaotong University from January 2000 to August 2012. Clinical data were analyzed, including diagnosis, cardiac functional grading, gestational weeks of delivery, delivery mode, birth weight, Apgar scores, etc.
Results: (1) Of all the 28 patients, 14 (50%) were diagnosed before pregnancy and others (50%) were diagnosed during pregnancy.(2) Four cases were obstructive HCM (14%), 3 with cardiac function grade I and 1 with grade II. Twenty four cases were non-obstructive HCM (86%), 14 with cardiac function grade I, 9 with grade II and 1 with grade IV. (3) Of all the 28 patients, 4 had family history, 18 (64%) had clinical symptoms or signs which occurred in 8-32 gestational weeks. Twenty-three cases had abnormal ECG (82%). Among them 21 had non-obstructive HCM (88%), with average interventricular septal thickness of (22 ± 3) mm. The other 2 patients had obstructive HCM, with average interventricular septal thickness of (23 ± 4) mm.7 patients (7/28, 25%) had mild-to-moderate pulmonary hypertension [6 with non-obstructive HCM (6/24, 25%) ], and 10 patients had abnormal myocardial enzyme spectrum or troponin levels [9 with non-obstructive HCM (9/24, 38%) ].(4) Among all the patients, only one had vaginal delivery and others received cesarean section. Twenty-two patients had term pregnancies and 6 had preterm birth. The average gestational weeks of delivery in non-obstructive HCM and obstructive HCM were (36.5 ± 2.5) and (38.5 ± 0.4) weeks, respectively. The average birth weight of neonates were (2684 ± 563) and (3164 ± 321) g, and Apgar scores were 9.9 and 10 (10 minutes) respectively. Patients transferred to NICU after delivery were 8 and 0. There was 1 maternal death (with non-obstructive HCM whose ejection fraction was only 26%) and no perinatal death.
Conclusions: More attention should be paid to the clinical signs and abnormal ECG.HCM could be definitely diagnosed by timely echocardiography. Patients with hypertrophic cardiomyopathy were mainly non-obstructive HCM, with cardiac function grade I and II. Monitoring the change of ejection fraction during pregnancy would help. Perinatal outcomes were fine.
Download full-text PDF |
Source |
---|
Animals (Basel)
November 2024
Veterinary Teaching Hospital, Tokyo University of Agriculture and Technology, Fuchu 183-0054, Tokyo, Japan.
Indian Heart J
December 2024
Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address:
Background: Data on the incidence of infective endocarditis (IE) in patients with hypertrophic cardiomyopathy (HCM) is sparse. This study evaluated a HCM cohort with aim to study the incidence of IE in these patients.
Methods: All patients entering the HCM cohort from May 2003 to June 2022 of a tertiary care hospital with at least one follow-up visit were included and followed up till June 2023.
Eur Heart J Qual Care Clin Outcomes
November 2024
Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Center, Rotterdam, The Netherlands.
Introduction: Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac disease. The impact of HCM on quality of life (QoL) and societal costs remains poorly understood. This prospective multi-centre burden of disease study estimated QoL and societal costs of genotyped HCM patients and genotype-positive phenotype-negative (G+/P-) subjects.
View Article and Find Full Text PDFClin Epidemiol
October 2024
Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Purpose: To assess the positive predictive value (PPV) of the diagnostic codes for hypertrophic cardiomyopathy (HCM) in the Danish National Patient Register (DNPR) and identify factors affecting the PPV.
Patients And Methods: We randomly sampled 200 patients registered in DNPR with the diagnostic codes DI421 (obstructive) or DI422 (non-obstructive) HCM, from Eastern Denmark, between December 1, 2017, and September 16, 2021. We assessed patients' medical records and classified whether the diagnosis of HCM was correct, incorrect, or uncertain according to the European Society of Cardiology (ESC) guidelines.
J Imaging Inform Med
October 2024
Department of Radiology, Research Center of Clinical Medical Imaging, The First Affiliated Hospital of Anhui Medical University, Anhui Province Clinical Image Quality Control Center, Hefei, 230032, Anhui Province, China.
To assess left atrial (LA) strain parameters using cardiovascular magnetic resonance imaging feature tracking (cardiac MRI-FT) for differentiating hypertensive heart disease (HHD) from hypertrophic cardiomyopathy (HCM), which are two left ventricular hypertrophic diseases that could present with similar morphologies in early stage but differ in clinical symptoms and treatment strategies. 45 patients with HHD, 85 patients with HCM (non-obstructive hypertrophic cardiomyopathy [HNCM, n = 45] and obstructive hypertrophic cardiomyopathy [HOCM, n = 40]) and 30 healthy controls (HC) were retrospectively included. LA volumes, strain, and strain rate were determined by manually contouring on the two- and four-chamber views of the CMR-FT module using CVI 42 software.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!